Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,190.00
Bid: 12,210.00
Ask: 12,214.00
Change: 162.00 (1.35%)
Spread: 4.00 (0.033%)
Open: 12,036.00
High: 12,214.00
Low: 12,024.00
Prev. Close: 12,028.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London open: Stocks slip as investors digest earnings, Barclays rises

Wed, 30th Jul 2014 08:26

- Barclays rises as investors digest wave of corporate earnings- Russian sanctions, Gaza and Argentina in focus- US economic data, Fed decision due out later ontechMARK 2,785.48 +0.12%FTSE 100 6,797.66 -0.15%FTSE 250 15,671.08 -0.10%UK markets opened slightly lower on Wednesday as investors digested a wave of corporate earnings and cautiously awaited economic data and a policy decision Stateside later on.Meanwhile, traders were still watching developments in the Ukraine crisis after US and EU leaders announced a fresh round of sanctions on Russia yesterday. Relentless fighting in Gaza and a potential debt default in Argentina were also likely to be weighing on risk appetite.The FTSE 100 was trading down 0.2% at 6,798 in early trading as strong gains from Barclays, Travis Perkins and AstraZeneca were offset by falls from Antofagasta, ITV and Tullow Oil.After a relatively quiet start to the week macro-wise, things will pick up today with a flurry of economic indicators due out during the morning session, including Eurozone confidence data and Germany inflation.However, the focus is likely to be on the US later on with the closely-watched ADP employment report and second-quarter gross domestic product (GDP) estimates due out before the opening bell on Wall Street, and the Federal Reserve's policy decision scheduled for this evening.Angus Campbell, Senior Analyst at FxPro, said that the GDP figures are "like to move the market most - this is because tonight's [Fed meeting] does not include a press conference and so there's unlikely to be any changes to what we saw or heard last month".Barclays leads banks higherBarclays was a high riser this morning as it reported a less-than-expected 12% fall in total income adjusted for insurance claims for the first half to £13.32bn, driven by reductions at its investment and African banking units. The consensus estimate had been for a drop to £13.23bn.Domestic banking peers RBS and Lloyds were also on the rise.Housebuilder Travis Perkins also impressed as it reported double-digit growth across the board in the first half, with like-for-like revenues up 10.2% and profits up 16%. The company said it expects "continued solid growth" for the rest of the year.Astrazeneca was in demand after it struck a deal with drug developer Almirall for the rights to the Spanish group's respiratory franchise. The initial consideration is $875m,Chile-focused mining group Antofagasta underwhelmed as it maintained its production guidance for 2014 after a sequential increase in output in the second quarter, while net cash costs were broadly flat.Shares of broadcaster ITV were in negative territory with the stock retreating after its recent strong run. Nevertheless, the company managed to beat expectations with its first-half results this morning with pre-tax profits up 16%.Also lower was Tullow Oil as it dropped into the red in the first half of 2014, after exploration write-offs more than doubled. Tullow reported a loss before tax of $29m in the first six months of the year, compared with a profit of $486m in the first half of 2013.FTSE 100 - RisersBarclays (BARC) 226.35p +3.31%Travis Perkins (TPK) 1,679.00p +2.07%Severn Trent (SVT) 1,955.00p +0.93%AstraZeneca (AZN) 4,353.00p +0.71%Royal Bank of Scotland Group (RBS) 356.20p +0.62%Capita (CPI) 1,222.00p +0.58%Carnival (CCL) 2,139.00p +0.56%BT Group (BT.A) 389.00p +0.52%Reckitt Benckiser Group (RB.) 5,245.00p +0.48%Vodafone Group (VOD) 203.70p +0.39%FTSE 100 - FallersAntofagasta (ANTO) 838.00p -1.99%Sainsbury (J) (SBRY) 318.40p -1.52%GKN (GKN) 360.60p -1.48%CRH (CRH) 1,442.00p -1.44%Compass Group (CPG) 994.00p -1.39%WPP (WPP) 1,196.00p -0.99%Rio Tinto (RIO) 3,441.00p -0.98%TUI Travel (TT.) 364.50p -0.84%Morrison (Wm) Supermarkets (MRW) 173.10p -0.80%Sports Direct International (SPD) 687.50p -0.79%FTSE 250 - RisersPets at Home Group (PETS) 182.30p +7.24%Riverstone Energy Limited (RSE) 925.00p +2.21%IP Group (IPO) 195.90p +2.14%Dignity (DTY) 1,408.00p +1.88%Perform Group (PER) 211.00p +1.78%National Express Group (NEX) 261.00p +1.68%Diploma (DPLM) 635.50p +1.68%Fisher (James) & Sons (FSJ) 1,337.00p +1.60%Taylor Wimpey (TW.) 116.40p +1.57%BTG (BTG) 616.00p +1.48%FTSE 250 - FallersVedanta Resources (VED) 1,057.00p -3.03%Jupiter Fund Management (JUP) 406.70p -2.02%Investec (INVP) 525.50p -1.78%Pace (PIC) 355.90p -1.66%Betfair Group (BET) 1,026.00p -1.63%Beazley (BEZ) 254.30p -1.59%Rotork (ROR) 2,767.00p -1.53%Spectris (SXS) 1,931.00p -1.48%International Personal Finance (IPF) 577.50p -1.45%Fenner (FENR) 337.60p -1.43%BC
More News
27 Nov 2023 09:20

LONDON BROKER RATINGS: Peel, Numis up Rightmove; Goldman cuts Entain

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
23 Nov 2023 18:41

IN BRIEF: AstraZeneca Chair Demare buys shares for over GBP200,000

AstraZeneca PLC - Cambridge-based pharmaceutical company - Chair Michel Demare buys 2,000 shares in total on Wednesday and Tuesday. Buys 1,000 shares for GBP101.05 each on Tuesday and 1,000 shares for GBP101.70 each on Thursday, for a total of GBP202,752.

Read more
20 Nov 2023 10:49

AstraZeneca launches new life sciences tech innovation firm Evinova

(Alliance News) - AstraZeneca PLC on Monday launched Evinova, a new health technology business focused on accelerating innovation across the life sciences sector, delivery of clinical trials and better health outcomes.

Read more
17 Nov 2023 15:20

London close: Stocks higher despite weaker retail sales data

(Sharecast News) - London's stock markets finished in a positive state on Friday despite weaker-than-expected UK retail sales figures.

Read more
17 Nov 2023 12:00

LONDON MARKET MIDDAY: Stocks shrug off downbeat UK retail sales

(Alliance News) - Stock prices in London were up at midday on Friday, as a week of favourable data as far as inflation goes gave investors a reason to overlook disappointing UK retail sales figures.

Read more
17 Nov 2023 09:03

LONDON MARKET OPEN: Stocks up despite UK retail sales growth miss

(Alliance News) - Stock prices in London opened higher on Friday, despite weaker-than-expected October retail sales figures for the UK.

Read more
17 Nov 2023 08:31

TOP NEWS: US approves AstraZeneca's Truqap for form of breast cancer

(Alliance News) - AstraZeneca PLC on Friday said that the US Food & Drug Administration approved its drug Truqap in combination with Faslodex to treat patients with an advanced form of breast cancer.

Read more
17 Nov 2023 07:58

LONDON BRIEFING: UK retail sales fall; AstraZeneca gets US approval

(Alliance News) - Stock prices in London are still set to open higher on Friday, despite October retail sales figures for the UK disappointing shortly before the opening bell.

Read more
17 Nov 2023 07:16

AstraZeneca gets US approval for breast cancer treatment

(Sharecast News) - AstraZeneca's 'Truqap', or capivasertib, in combination with 'Faslodex', or fulvestrant, has secured approval from the US Food and Drug Administration (FDA) for specific breast cancer treatments, the company announced on Friday.

Read more
14 Nov 2023 10:51

TOP NEWS: AstraZeneca Imfinzi fails to meet endpoint in cancer trial

(Alliance News) - AstraZeneca PLC on Tuesday said the Pacific-2 phase III trial for Imfinzi as an early treatment lung cancer immunotherapy treatment administered with chemoradiotherapy, did not meet its primary endpoint.

Read more
14 Nov 2023 09:22

AstraZeneca's latest lung cancer trial fails its primary endpoint

(Sharecast News) - AstraZeneca announced on Tuesday that its 'PACIFIC-2' phase three trial for Imfinzi, or durvalumab, concurrently administered with chemoradiotherapy (CRT), did not achieve its primary endpoint of progression-free survival compared to CRT alone.

Read more
13 Nov 2023 09:45

LONDON BROKER RATINGS: Diageo gets price target cuts; JPMorgan ups M&G

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
9 Nov 2023 15:02

London close: Stocks gain as investors await Powell speech

(Sharecast News) - London's stock markets were buoyant at the close of trading on Thursday, influenced by Chinese inflation data, a substantial influx of corporate news, and a speech from the Fed chair later in the global day.

Read more
9 Nov 2023 12:06

LONDON MARKET MIDDAY: FTSE up despite higher for longer US rates fear

(Alliance News) - European equities were on the up on Thursday, despite lingering US interest rate worries and poor China data.

Read more
9 Nov 2023 11:02

Lancashire Holdings declares special dividend after strong year so far

(Alliance News) - Lancashire Holdings Ltd on Thursday said it approved a capital return of up to USD169 million, and it reported rising gross premiums written for the year-to-date.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.